Guardant Health, Inc.
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
GH$155.35-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
(in thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net loss | $(416,277) | $(436,373) | $(479,449) |
| Other comprehensive income (loss): | |||
| Unrealized (loss) gain on available-for-sale securities | (142) | 244 | 16,758 |
| Foreign currency translation adjustments | 491 | (1,770) | (911) |
| Other comprehensive income (loss) | 349 | (1,526) | 15,847 |
| Comprehensive loss | $(415,928) | $(437,899) | $(463,602) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.